WE-REACH
March 26, 2020
WE-REACH Executive Director Talks Covid-19 with USA Today, Salon, and Geekwire
Dr. Rodney Ho, the Principal Investigator (PI) and Director of the Center for WE-REACH talked with USA Today, Salon, and Geekwire to discuss remdesivir, lopinavir, and hydrocholoroquinine as potential treatments for Covid-19.
As part of the center’s focus on providing scientists a bridge to medical impact, WE-REACH has prepared a list of funding opportunities with the NIH. For additional opportunities, see WE-REACH partner ITHS.